Visalytics
Visalytics
approved EB-1A RFE Issued

Postdoctoral Research Associate

Biomedical Engineering · India · 2025-05-02

Processing Time
544 days
Decision Date
2025-05-02
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

4 of 3 criteria met
Scholarly Articles (Met)

Authored 17 peer-reviewed publications in internationally acclaimed journals.

Judging (Met)

Completed over 20 peer reviews for prominent journals and served as an editorial board member.

Original Contributions (Met)

Developed innovative nanomaterials and machine learning technologies for disease detection and cancer treatment.

Memberships (Met)

Served as an editorial board member for Frontiers in Nanotechnology, evidencing an esteemed reputation.

Why This Petition Was Approved

The petition was approved based on 17 peer-reviewed publications, with 8 ranking in the top 1-10% of most-cited articles. Her 803 citations and service on the editorial board of Frontiers in Nanotechnology satisfied the EB-1A criteria for scholarly articles, original contributions, and judging. The evidence demonstrated her position in the top 1% of researchers in Biomedical Engineering.

Request for Evidence (RFE)

Successfully Addressed

The RFE required more evidence of the global impact and significance of the client's research. The response provided detailed metrics on citation rankings and expert affirmations of the work's importance to U.S. public health.

RFE Targets
Original ContributionsScholarly Articles

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Judging Experience
Original Contributions
Evidence Submitted
  • 17 peer-reviewed scientific publications in international journals
  • 803 global citations (top 1% in field)
  • 20+ peer reviews for journals such as Biomaterials Research
  • Editorial board membership for Frontiers in Nanotechnology
  • Development of nano-silver-enhanced mass spectrometry platforms
  • Synthesis of novel therapeutic compounds for liver cancer

Similar Cases

Postdoctoral Researcher

Biotechnology · Bangladesh

WeGreened EB-1A approved
Massachusetts 14 days 2025-05-21
The petition was approved based on a scholarly portfolio of 15 peer-reviewed publications in top-tier journals like Nature Methods and PNAS, which garnered 254 citations. The petitioner demonstrated professional standing through over 18 peer reviews for high-impact journals and service on editorial boards. Additionally, the research attracted funding from prestigious bodies including the NIH, NSF, and National Cancer Institute.
View Case

Research Fellow

Biotechnology · China

WeGreened EB-1A approved
Massachusetts 15 days 2025-03-18
The petition was approved based on 7 peer-reviewed journal articles in high-impact publications and over 500 citations demonstrating global influence. Additionally, the petitioner completed over 90 peer reviews for leading journals, satisfying the judging criterion. These metrics, combined with evidence of original scientific contributions to medical innovation and biosecurity, met the EB-1A requirements.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-1A approved
369 days 2025-01-15
The petition was approved based on the petitioner's 47 peer-reviewed publications in top-tier journals and a high citation count of 2,811. Additionally, her 48 journal reviews served as evidence of her judging the work of others. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging roles.
View Case

Postdoctoral Researcher

Biotechnology

WeGreened EB-1A approved
New York 8 days 2025-05-08
The petition satisfied the EB-1A criteria through a high citation count of 4,265 and an h-index of 17, placing the applicant in the top 3% of researchers in medicine. Approval was further supported by a robust publication record in top-tier journals and extensive experience performing over 30 peer reviews for prestigious publications like Science Immunology.
View Case

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-02.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 544 days
RFE Issued
Criteria Met 4 / 3
Evidence Types 6

EB-1A Case Data

Scraped Case Data

Total Cases 919
Success Rate 53.0%
Sustained 487
Dismissed 315

Related Pages

EB-1A Overview EB-1A in India All EB-1A Cases EB-1A Dashboard

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist